132 related articles for article (PubMed ID: 28371444)
1. Sequence-Defined Oligoamide Drug Conjugates of Pretubulysin and Methotrexate for Folate Receptor Targeted Cancer Therapy.
Truebenbach I; Gorges J; Kuhn J; Kern S; Baratti E; Kazmaier U; Wagner E; Lächelt U
Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28371444
[TBL] [Abstract][Full Text] [Related]
2. Combined antitumoral effects of pretubulysin and methotrexate.
Kern S; Truebenbach I; Höhn M; Gorges J; Kazmaier U; Zahler S; Vollmar AM; Wagner E
Pharmacol Res Perspect; 2019 Feb; 7(1):e00460. PubMed ID: 30693087
[TBL] [Abstract][Full Text] [Related]
3. Synthetic polyglutamylation of dual-functional MTX ligands for enhanced combined cytotoxicity of poly(I:C) nanoplexes.
Lächelt U; Wittmann V; Müller K; Edinger D; Kos P; Höhn M; Wagner E
Mol Pharm; 2014 Aug; 11(8):2631-9. PubMed ID: 24754871
[TBL] [Abstract][Full Text] [Related]
4. Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.
Thomas TP; Huang B; Choi SK; Silpe JE; Kotlyar A; Desai AM; Zong H; Gam J; Joice M; Baker JR
Mol Pharm; 2012 Sep; 9(9):2669-2676. PubMed ID: 22827500
[TBL] [Abstract][Full Text] [Related]
5. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.
Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F
Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133
[TBL] [Abstract][Full Text] [Related]
6. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
[TBL] [Abstract][Full Text] [Related]
7. Bifunctional PAMAM dendrimer conjugates of folic acid and methotrexate with defined ratio.
Zong H; Thomas TP; Lee KH; Desai AM; Li MH; Kotlyar A; Zhang Y; Leroueil PR; Gam JJ; Banaszak Holl MM; Baker JR
Biomacromolecules; 2012 Apr; 13(4):982-91. PubMed ID: 22360561
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy.
Leamon CP; Reddy JA; Vlahov IR; Dorton R; Bloomfield A; Vetzel M; Klein PJ; Westrick E; Xu LC; Wang Y
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1151-1160. PubMed ID: 28451831
[TBL] [Abstract][Full Text] [Related]
9. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
10. Post-PEGylation of siRNA Lipo-oligoamino Amide Polyplexes Using Tetra-glutamylated Folic Acid as Ligand for Receptor-Targeted Delivery.
Müller K; Kessel E; Klein PM; Höhn M; Wagner E
Mol Pharm; 2016 Jul; 13(7):2332-45. PubMed ID: 27177200
[TBL] [Abstract][Full Text] [Related]
11. Combination Chemotherapy of L1210 Tumors in Mice with Pretubulysin and Methotrexate Lipo-Oligomer Nanoparticles.
Truebenbach I; Kern S; Loy DM; Höhn M; Gorges J; Kazmaier U; Wagner E
Mol Pharm; 2019 Jun; 16(6):2405-2417. PubMed ID: 31025870
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-conjugated quantum dots: synthesis, characterisation and cytotoxicity in drug resistant cancer cells.
Johari-Ahar M; Barar J; Alizadeh AM; Davaran S; Omidi Y; Rashidi MR
J Drug Target; 2016; 24(2):120-33. PubMed ID: 26176269
[TBL] [Abstract][Full Text] [Related]
13. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
Leamon CP; Reddy JA; Vetzel M; Dorton R; Westrick E; Parker N; Wang Y; Vlahov I
Cancer Res; 2008 Dec; 68(23):9839-44. PubMed ID: 19047164
[TBL] [Abstract][Full Text] [Related]
14. Novel folate-hydroxamate based antimetabolites: synthesis and biological evaluation.
Carrasco MP; Enyedy EA; Krupenko NI; Krupenko SA; Nuti E; Tuccinardi T; Santamaria S; Rossello A; Martinelli A; Santos MA
Med Chem; 2011 Jul; 7(4):265-74. PubMed ID: 21568878
[TBL] [Abstract][Full Text] [Related]
15. Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
Thomas TP; Majoros IJ; Kotlyar A; Kukowska-Latallo JF; Bielinska A; Myc A; Baker JR
J Med Chem; 2005 Jun; 48(11):3729-35. PubMed ID: 15916424
[TBL] [Abstract][Full Text] [Related]
16. Folic acid-modified methotrexate-conjugated gold nanoparticles as nano-sized trojans for drug delivery to folate receptor-positive cancer cells.
Yücel O; Şengelen A; Emik S; Önay-Uçar E; Arda N; Gürdağ G
Nanotechnology; 2020 Aug; 31(35):355101. PubMed ID: 32413875
[TBL] [Abstract][Full Text] [Related]
17. Enhanced toxicity and cellular uptake of methotrexate-conjugated nanoparticles in folate receptor-positive cancer cells by decorating with folic acid-conjugated d-α-tocopheryl polyethylene glycol 1000 succinate.
Junyaprasert VB; Dhanahiranpruk S; Suksiriworapong J; Sripha K; Moongkarndi P
Colloids Surf B Biointerfaces; 2015 Dec; 136():383-93. PubMed ID: 26433645
[TBL] [Abstract][Full Text] [Related]
18. Augmented anticancer activity of a targeted, intracellularly activatable, theranostic nanomedicine based on fluorescent and radiolabeled, methotrexate-folic Acid-multiwalled carbon nanotube conjugate.
Das M; Datir SR; Singh RP; Jain S
Mol Pharm; 2013 Jul; 10(7):2543-57. PubMed ID: 23683251
[TBL] [Abstract][Full Text] [Related]
19. Tumor Targeting with Small Molecule-Drug Conjugates (SMDCs) - Can They be Better than ADCs?
Altmann KH
Chimia (Aarau); 2018 Mar; 72(3):154-155. PubMed ID: 29631670
[No Abstract] [Full Text] [Related]
20. Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells.
Barar J; Kafil V; Majd MH; Barzegari A; Khani S; Johari-Ahar M; Asgari D; Coukos G; Omidi Y
J Nanobiotechnology; 2015 Mar; 13():26. PubMed ID: 25880772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
